Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Franz Rischard
Professor, Medicine - (Clinical Scholar Track)
Medicine
Overview
Research
More
Collaboration
(45)
Daniel Taylor
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Jordan Karp
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Edward Bedrick
Mutual work: 4 Proposals﹒5 Publications
Collaboration Details
Sairam Parthasarathy
Mutual work: 3 Grants﹒6 Proposals
Collaboration Details
Zhao Chen
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Page 1 of 9
Previous page
Next page
Grants
(62)
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $1.8M
·
External
Co-Investigator (COI)
viral persistence,
immune dysregulation,
interventions evaluation,
sars-cov-2,
post-acute sequelae
A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patient
Active
·
2023
·
$509.1K
·
External
Principal Investigator (PI)
pulmonary hypertension,
right ventricular remodeling,
treprostinil therapy,
pulmonary artery pressure
A Phase 2b, Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Treprostinil Palmitil Inhalation Powder (TPIP)
Active
·
2023
·
$450K
·
External
Principal Investigator (PI)
pharmacokinetics,
drug safety,
clinical trial,
pulmonary hypertension,
drug efficacy
IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002
Active
·
2023
·
$1.7M / $436.7K
·
External
Principal Investigator (PI)
pulmonary arterial hypertension,
long-term safety,
av-101
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hyper
Active
·
2023
·
$288.2K
·
External
Principal Investigator (PI)
clinical trials,
pulmonary arterial hypertension,
drug efficacy,
safety evaluation
Page 1 of 13
Previous page
Next page
Publications
(95)
Recent
Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension
2023
hemodynamics,
pulmonary hypertension,
rv function,
cluster analysis,
subphenotypes
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
2023
pulmonary arterial hypertension,
right ventricular function,
classification,
predictors,
functional recovery
Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex
2022
cytokine profiling,
pulmonary arterial hypertension,
redox homeostasis,
sex,
inflammation
Selonsertib in adults with pulmonary arterial hypertension ARROW) a randomised, double-blind, placebo-controlled, phase 2 trial
2022
pulmonary arterial hypertension,
selonsertib,
double-blind,
placebo-controlled
Oxygen Utilization as a Primary Mediator of Age-Related Functional Decline in Pulmonary Arterial Hypertension
2022
oxygen utilization,
age-related functional decline,
pulmonary arterial hypertension,
mediator,
research
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease
2022
pulmonary vascular disease,
transplant-free survival,
clinical characteristics,
research,
health outcomes
To Drain or Not to Drain: Hemodynamic Characterization of Tamponade in PAH
2022
cardiovascular hemodynamics,
pulmonary hypertension,
tamponade,
cardiac function,
fluid dynamics
The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension.
2022
pulmonary hypertension,
cardiovascular health,
therapeutic response,
diastolic function,
right ventricular function
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
2022
pulmonary hypertension,
inhaled treprostinil,
parenchymal lung disease,
efficacy,
increase trial
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension
2022
cardiopulmonary exercise testing,
pulmonary arterial hypertension,
incremental value,
intermediate-risk,
exercise testing